메뉴 건너뛰기




Volumn 12, Issue 9, 2010, Pages 708-717

Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; B RAF KINASE; GENOMIC DNA; GLYCINE; H RAS PROTEIN; K RAS PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN N RAS; PROTEIN TYROSINE KINASE; RAS PROTEIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

EID: 77956836493     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.10356     Document Type: Article
Times cited : (42)

References (52)
  • 1
    • 0016271462 scopus 로고
    • Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases
    • Spiro RH, Huvos AG, and Strong EW (1974). Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg 128, 512-520.
    • (1974) Am J Surg , vol.128 , pp. 512-520
    • Spiro, R.H.1    Huvos, A.G.2    Strong, E.W.3
  • 2
    • 77956829338 scopus 로고    scopus 로고
    • Salivary gland diseases
    • Clinical Pathology Correlations. JA Regezi, JJ Sciubba, and RCK Jordan (Eds). Saunders, St Louis, MO
    • Carlson ER, Kim J, Mirowski GW, Stewart JCB, and Zarbo RJ (2008). Salivary gland diseases. In Oral Pathology: Clinical Pathology Correlations. JA Regezi, JJ Sciubba, and RCK Jordan (Eds). Saunders, St Louis, MO. pp. 179-215.
    • (2008) Oral Pathology , pp. 179-215
    • Carlson, E.R.1    Kim, J.2    Mirowski, G.W.3    Stewart, J.C.B.4    Zarbo, R.J.5
  • 3
    • 67649494469 scopus 로고    scopus 로고
    • Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2
    • Phuchareon J, Ohta Y, Woo JM, Eisele DW, and Tetsu O (2009). Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One 4, e6040.
    • (2009) PLoS One , vol.4 , pp. 6040
    • Phuchareon, J.1    Ohta, Y.2    Woo, J.M.3    Eisele, D.W.4    Tetsu, O.5
  • 4
    • 33847324517 scopus 로고    scopus 로고
    • Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: What is the role of elective neck irradiation?
    • Chen AM, Garcia J, Lee NY, Bucci MK, and Eisele DW (2007). Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67, 988-994.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 988-994
    • Chen, A.M.1    Garcia, J.2    Lee, N.Y.3    Bucci, M.K.4    Eisele, D.W.5
  • 5
    • 33748181930 scopus 로고    scopus 로고
    • Systemic therapy in the palliative management of advanced salivary gland cancers
    • Laurie SA and Licitra L (2006). Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 24, 2673-2678.
    • (2006) J Clin Oncol , vol.24 , pp. 2673-2678
    • Laurie, S.A.1    Licitra, L.2
  • 6
    • 0034213931 scopus 로고    scopus 로고
    • RTK mutations and human syndromes when good receptors turn bad
    • Robertson SC, Tynan JA, and Donoghue DJ (2000). RTK mutations and human syndromes when good receptors turn bad. Trends Genet 16, 265-271.
    • (2000) Trends Genet , vol.16 , pp. 265-271
    • Robertson, S.C.1    Tynan, J.A.2    Donoghue, D.J.3
  • 10
    • 0030999238 scopus 로고    scopus 로고
    • Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-Kit, phosphatidylinositol 3-kinase, and p120 (CBL)
    • Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, and Griffin JD (1997). Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-Kit, phosphatidylinositol 3-kinase, and p120 (CBL). J Biol Chem 272, 10248-10253.
    • (1997) J Biol Chem , vol.272 , pp. 10248-10253
    • Sattler, M.1    Salgia, R.2    Shrikhande, G.3    Verma, S.4    Pisick, E.5    Prasad, K.V.6    Griffin, J.D.7
  • 11
    • 0033981729 scopus 로고    scopus 로고
    • Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility
    • Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, and Hunter T (2000). Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat Genet 24, 157-162.
    • (2000) Nat Genet , vol.24 , pp. 157-162
    • Blume-Jensen, P.1    Jiang, G.2    Hyman, R.3    Lee, K.F.4    O'Gorman, S.5    Hunter, T.6
  • 12
    • 0033619142 scopus 로고    scopus 로고
    • Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-Kit mediated activation of the Ras/MAP kinase pathway and c-fos induction
    • Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, and Rönnstrand L (1999). Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-Kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene 18, 5546-5553.
    • (1999) Oncogene , vol.18 , pp. 5546-5553
    • Lennartsson, J.1    Blume-Jensen, P.2    Hermanson, M.3    Pontén, E.4    Carlberg, M.5    Rönnstrand, L.6
  • 13
    • 38349094750 scopus 로고    scopus 로고
    • Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and Raf inhibition: Implications for therapeutic options
    • Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, and Tetsu O (2008). Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and Raf inhibition: implications for therapeutic options. Hum Mol Genet 17, 419-430.
    • (2008) Hum Mol Genet , vol.17 , pp. 419-430
    • Senawong, T.1    Phuchareon, J.2    Ohara, O.3    McCormick, F.4    Rauen, K.A.5    Tetsu, O.6
  • 15
    • 0032873349 scopus 로고    scopus 로고
    • KIT protein expression and analysis of c-Kit gene mutation in adenoid cystic carcinoma
    • Holst VA, Marshall CE, Moskaluk CA, and Frierson HF Jr (1999). KIT protein expression and analysis of c-Kit gene mutation in adenoid cystic carcinoma. Mod Pathol 12, 956-960.
    • (1999) Mod Pathol , vol.12 , pp. 956-960
    • Holst, V.A.1    Marshall, C.E.2    Moskaluk, C.A.3    Frierson Jr, H.F.4
  • 16
    • 0346992281 scopus 로고    scopus 로고
    • Expression of KIT (CD117) in neoplasms of the head and neck: An ancillary marker for adenoid cystic carcinoma
    • Mino M, Pilch BZ, and Faquin WC (2003). Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 16, 1224-1231.
    • (2003) Mod Pathol , vol.16 , pp. 1224-1231
    • Mino, M.1    Pilch, B.Z.2    Faquin, W.C.3
  • 17
    • 20044384866 scopus 로고    scopus 로고
    • Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-Kit: A Princess Margaret Hospital phase II consortium study
    • Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, and Siu LL (2005). Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-Kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 23, 585-590.
    • (2005) J Clin Oncol , vol.23 , pp. 585-590
    • Hotte, S.J.1    Winquist, E.W.2    Lamont, E.3    Mackenzie, M.4    Vokes, E.5    Chen, E.X.6    Brown, S.7    Pond, G.R.8    Murgo, A.9    Siu, L.L.10
  • 18
    • 23344444802 scopus 로고    scopus 로고
    • Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer
    • Bruce IA, Slevin NJ, Homer JJ, McGown AT, and Ward TH (2005). Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer. Anticancer Drugs 16, 719-726.
    • (2005) Anticancer Drugs , vol.16 , pp. 719-726
    • Bruce, I.A.1    Slevin, N.J.2    Homer, J.J.3    McGown, A.T.4    Ward, T.H.5
  • 19
    • 71849114124 scopus 로고    scopus 로고
    • The rational treatment of cancer
    • RAWeinberg (Ed). Garland Science, New York, NY
    • Weinberg RA (2007). The rational treatment of cancer. In The Biology of Cancer. RAWeinberg (Ed). Garland Science, New York, NY. pp. 725-796.
    • (2007) The Biology of Cancer , pp. 725-796
    • Weinberg, R.A.1
  • 20
    • 4344564244 scopus 로고    scopus 로고
    • Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated cases
    • Alcedo JC, Fabrega JM, Arosemena JR, and Urrutia A (2004). Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck 26, 829-831.
    • (2004) Head Neck , vol.26 , pp. 829-831
    • Alcedo, J.C.1    Fabrega, J.M.2    Arosemena, J.R.3    Urrutia, A.4
  • 21
    • 24944587262 scopus 로고    scopus 로고
    • Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands
    • Faivre S, Raymond E, Casiraghi O, Temam S, and Berthaud P (2005). Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol 23, 6271-6273.
    • (2005) J Clin Oncol , vol.23 , pp. 6271-6273
    • Faivre, S.1    Raymond, E.2    Casiraghi, O.3    Temam, S.4    Berthaud, P.5
  • 22
    • 58949089442 scopus 로고    scopus 로고
    • Hyalinizing clear cell carcinoma: Case series and comprehensive review of the literature
    • Solar AA, Schmidt BL, and Jordan RC (2009). Hyalinizing clear cell carcinoma: case series and comprehensive review of the literature. Cancer 115, 75-83.
    • (2009) Cancer , vol.115 , pp. 75-83
    • Solar, A.A.1    Schmidt, B.L.2    Jordan, R.C.3
  • 23
    • 0033119801 scopus 로고    scopus 로고
    • Catenin regulates expression of cyclin D1 in colon carcinoma cells
    • Tetsu O and McCormick F (1999). Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
    • (1999) Nature , vol.398 , pp. 422-426
    • Tetsu, O.1    McCormick, F.2
  • 24
    • 77954641921 scopus 로고    scopus 로고
    • Growth factors, receptors, and cancer
    • RA Weinberg (Ed). Garland Science, New York, NY
    • Weinberg RA (2007). Growth factors, receptors, and cancer. In The Biology of Cancer. RA Weinberg (Ed). Garland Science, New York, NY. pp. 119-158.
    • (2007) The Biology of Cancer , pp. 119-158
    • Weinberg, R.A.1
  • 26
    • 0036493872 scopus 로고    scopus 로고
    • The c-Kit mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
    • Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, and Longley BJ (2002). The c-Kit mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99, 1741-1744.
    • (2002) Blood , vol.99 , pp. 1741-1744
    • Ma, Y.1    Zeng, S.2    Metcalfe, D.D.3    Akin, C.4    Dimitrijevic, S.5    Butterfield, J.H.6    McMahon, G.7    Longley, B.J.8
  • 27
    • 4444230149 scopus 로고    scopus 로고
    • Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase
    • Foster R, Griffith R, Ferrao P, and Ashman L (2004). Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase. J Mol Graph Model 23, 139-152.
    • (2004) J Mol Graph Model , vol.23 , pp. 139-152
    • Foster, R.1    Griffith, R.2    Ferrao, P.3    Ashman, L.4
  • 28
    • 33947520803 scopus 로고    scopus 로고
    • Juxtamembrane-type c-Kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation
    • Nakagomi N and Hirota S (2007). Juxtamembrane-type c-Kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation. Lab Invest 87, 365-371.
    • (2007) Lab Invest , vol.87 , pp. 365-371
    • Nakagomi, N.1    Hirota, S.2
  • 32
    • 0023885845 scopus 로고
    • Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins
    • Feig LA and Cooper GM (1988). Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol Cell Biol 8, 2472-2478.
    • (1988) Mol Cell Biol , vol.8 , pp. 2472-2478
    • Feig, L.A.1    Cooper, G.M.2
  • 33
    • 0037849951 scopus 로고    scopus 로고
    • Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization
    • Matallanas D, Arozarena I, Berciano MT, Aaronson DS, Pellicer A, Lafarga M, and Crespo P (2003). Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 278, 4572-4581.
    • (2003) J Biol Chem , vol.278 , pp. 4572-4581
    • Matallanas, D.1    Arozarena, I.2    Berciano, M.T.3    Aaronson, D.S.4    Pellicer, A.5    Lafarga, M.6    Crespo, P.7
  • 35
    • 0024292722 scopus 로고
    • Most human carcinomas of the exocrine pancreas contain mutant c-K-Ras genes
    • Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, and Perucho M (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-Ras genes. Cell 53, 549-554.
    • (1988) Cell , vol.53 , pp. 549-554
    • Almoguera, C.1    Shibata, D.2    Forrester, K.3    Martin, J.4    Arnheim, N.5    Perucho, M.6
  • 37
    • 18444374405 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in human cancer
    • Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J,Woffendin H, Garnett MJ, Bottomley W, et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
    • (2002) Nature , vol.417 , pp. 949-954
    • Davies, H.1    Bignell, G.R.2    Cox, C.3    Stephens, P.4    Edkins, S.5    Clegg, S.6
  • 39
    • 0842303173 scopus 로고    scopus 로고
    • Reversibility of oncogene-induced cancer
    • Felsher DW (2004). Reversibility of oncogene-induced cancer. Curr Opin Genet Dev 14, 37-42.
    • (2004) Curr Opin Genet Dev , vol.14 , pp. 37-42
    • Felsher, D.W.1
  • 40
    • 0025940323 scopus 로고
    • Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism
    • Giebel LB and Spritz RA (1991). Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 88, 8696-8699.
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 8696-8699
    • Giebel, L.B.1    Spritz, R.A.2
  • 42
    • 0023694835 scopus 로고
    • The proto-oncogene c-Kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
    • Chabot B, Stephenson DA, Chapman VM, Besmer P, and Bernstein A (1988). The proto-oncogene c-Kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335, 88-89.
    • (1988) Nature , vol.335 , pp. 88-89
    • Chabot, B.1    Stephenson, D.A.2    Chapman, V.M.3    Besmer, P.4    Bernstein, A.5
  • 43
    • 0024280901 scopus 로고
    • The dominant-white spotting (W) locus of the mouse encodes the c-Kit proto-oncogene
    • Geissler EN, Ryan MA, and Housman DE (1988). The dominant-white spotting (W) locus of the mouse encodes the c-Kit proto-oncogene. Cell 55, 185-192.
    • (1988) Cell , vol.55 , pp. 185-192
    • Geissler, E.N.1    Ryan, M.A.2    Housman, D.E.3
  • 44
    • 0031964940 scopus 로고    scopus 로고
    • Piebaldism with deafness: Molecular evidence for an expanded syndrome
    • Spritz RA and Beighton P (1998). Piebaldism with deafness: molecular evidence for an expanded syndrome. Am J Med Genet 75, 101-103.
    • (1998) Am J Med Genet , vol.75 , pp. 101-103
    • Spritz, R.A.1    Beighton, P.2
  • 47
    • 0036770178 scopus 로고    scopus 로고
    • Identification and treatment of chemoresistant inoperable or metastatic GIST: Experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)
    • Demetri GD (2002). Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Eur J Cancer 38(Suppl 5), S52-S59.
    • (2002) Eur J Cancer , vol.38 , Issue.SUPPL 5
    • Demetri, G.D.1
  • 48
    • 0029822816 scopus 로고    scopus 로고
    • Involvement of transcription factor encoded by the mi locus in the expression of c-Kit receptor tyrosine kinase in cultured mast cells of mice
    • Tsujimura T, Morii E, Nozaki M, Hashimoto K, Moriyama Y, Takebayashi K, Kondo T, Kanakura Y, and Kitamura Y (1996). Involvement of transcription factor encoded by the mi locus in the expression of c-Kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88, 1225-1233.
    • (1996) Blood , vol.88 , pp. 1225-1233
    • Tsujimura, T.1    Morii, E.2    Nozaki, M.3    Hashimoto, K.4    Moriyama, Y.5    Takebayashi, K.6    Kondo, T.7    Kanakura, Y.8    Kitamura, Y.9
  • 49
    • 0027204149 scopus 로고
    • Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loophelix- zipper protein
    • Hodgkinson CA, Moore KJ, Nakayama A, Steingrímsson E, Copeland NG, Jenkins NA, and Arnheiter H (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loophelix- zipper protein. Cell 74, 395-404.
    • (1993) Cell , vol.74 , pp. 395-404
    • Hodgkinson, C.A.1    Moore, K.J.2    Nakayama, A.3    Steingrímsson, E.4    Copeland, N.G.5    Jenkins, N.A.6    Arnheiter, H.7
  • 51
    • 33746565431 scopus 로고    scopus 로고
    • Lineage dependency and lineage-survival oncogenes in human cancer
    • Garraway LA and Sellers WR (2006). Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6, 593-602.
    • (2006) Nat Rev Cancer , vol.6 , pp. 593-602
    • Garraway, L.A.1    Sellers, W.R.2
  • 52
    • 0002608471 scopus 로고    scopus 로고
    • Growth factor receptors in cell transformation
    • G Peters and KH Vousden (Eds). Oxford University Press, Oxford, UK
    • Carl-Henrik H and Ronnstrand L (1997). Growth factor receptors in cell transformation. In Oncogenes and Tumor Suppressors. G Peters and KH Vousden (Eds). Oxford University Press, Oxford, UK. pp. 55-85.
    • (1997) Oncogenes and Tumor Suppressors , pp. 55-85
    • Carl-Henrik, H.1    Ronnstrand, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.